Mingyang Song is an Associate Professor in Clinical Epidemiology and Nutrition Epidemiology at Harvard T.H. Chan School of Public Health. His research centers around clinical translational epidemiology and cancer, particularly on integrating large-scale observational studies with biomarker-based randomized clinical trials to identify novel nutritional and gut microbiota-targeted strategies for cancer prevention and treatment. His work involves the integration of electronic health record (EHR) data and molecular profiling to develop cost-effective risk assessment tools for precision cancer screening and surveillance. He has received the NextGen Star Award from the American Association for Cancer Research and is currently supported by research grants from the National Cancer Institute and the American Cancer Society. Mingyang has extensively studied the roles that diet and lifestyle factors, in conjunction with host immune factors and gut microbiota, play in the development and survivorship of colorectal cancer. His findings have been based on data from large prospective cohort studies and involve leading biomarker-based clinical trials. He also chairs the Microbiome Epidemiology Working Group at Harvard and is a co-investigator on the Microbiome Nurses Study, which aims to establish the world’s largest prospective collection of microbiome specimens from 25,000 individuals.
Harvard T.H. Chan School of Public Health • Boston, MA
Associate Professor in Clinical Epidemiology and Nutrition Epidemiology.